Rising Company Profile
What is the competitive landscape for RISING
RISING has three hundred and thirty-six approved drugs.
There are three tentative approvals on RISING drugs.
Summary for Rising
| US Patents: | 0 |
| Tradenames: | 260 |
| Ingredients: | 253 |
| NDAs: | 336 |
Drugs and US Patents for Rising
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | GRANISETRON HYDROCHLORIDE | granisetron hydrochloride | INJECTABLE;INJECTION | 079078-002 | Sep 14, 2009 | AP | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | OSELTAMIVIR PHOSPHATE | oseltamivir phosphate | CAPSULE;ORAL | 210157-001 | Jan 21, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | LORAZEPAM | lorazepam | INJECTABLE;INJECTION | 200217-002 | Apr 4, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | FLUOCINOLONE ACETONIDE | fluocinolone acetonide | OIL;TOPICAL | 090982-001 | Apr 25, 2016 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | NIFEDIPINE | nifedipine | TABLET, EXTENDED RELEASE;ORAL | 201071-002 | Dec 3, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | ZOLMITRIPTAN | zolmitriptan | TABLET, ORALLY DISINTEGRATING;ORAL | 202855-002 | Sep 20, 2019 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Rising | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 040652-001 | Dec 11, 2006 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Rising
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Rising | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 7,553,835 | ⤷ Start Trial |
| Rising | ALFENTA | alfentanil hydrochloride | INJECTABLE;INJECTION | 019353-001 | Dec 29, 1986 | 4,167,574 | ⤷ Start Trial |
| Rising | OPTIVAR | azelastine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021127-001 | May 22, 2000 | 5,164,194 | ⤷ Start Trial |
| Rising | SULFAMYLON | mafenide acetate | CREAM;TOPICAL | 016763-001 | Approved Prior to Jan 1, 1982 | 3,497,599 | ⤷ Start Trial |
| Rising | EXTINA | ketoconazole | AEROSOL, FOAM;TOPICAL | 021738-001 | Jun 12, 2007 | 8,026,238 | ⤷ Start Trial |
| Rising | SUFENTA PRESERVATIVE FREE | sufentanil citrate | INJECTABLE;INJECTION | 019050-001 | May 4, 1984 | 3,998,834 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for RISING drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Ophthalmic Solution | 0.05% | ➤ Subscribe | 2006-12-13 |
| ➤ Subscribe | Foam | 2% | ➤ Subscribe | 2009-07-30 |
| ➤ Subscribe | Nasal Spray | 0.125 mg base/spray | ➤ Subscribe | 2005-11-14 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
